Open Access. Powered by Scholars. Published by Universities.®
- Institution
-
- Chapman University (59)
- University of Mississippi (4)
- James Madison University (2)
- University of Nebraska at Omaha (2)
- University of New Mexico (2)
-
- University of South Carolina (2)
- Arcadia University (1)
- Bellarmine University (1)
- Belmont University (1)
- Boise State University (1)
- Brigham Young University (1)
- Central Washington University (1)
- City University of New York (CUNY) (1)
- Claremont Colleges (1)
- Duquesne University (1)
- Florida Institute of Technology (1)
- Kutztown University (1)
- Longwood University (1)
- Otterbein University (1)
- Seattle Pacific University (1)
- Southern Methodist University (1)
- St. John Fisher University (1)
- Taiwan Food and Drug Administration (1)
- Technological University Dublin (1)
- The Texas Medical Center Library (1)
- The University of San Francisco (1)
- University of Arkansas, Fayetteville (1)
- University of Central Florida (1)
- University of Kentucky (1)
- University of Malaya (1)
- Keyword
-
- Blood-brain barrier (4)
- Cancer (4)
- Cerebral microbleeds (4)
- Cerebral microhemorrhage (4)
- Inflammation (4)
-
- Pharmacokinetics (4)
- Aging (3)
- Alzheimer’s disease (3)
- CYP3A (3)
- Chemotherapy (3)
- Cytotoxicity (3)
- Nanoparticles (3)
- Pain (3)
- Transferrin receptor (3)
- Animal models (2)
- Biofilm (2)
- Blood–brain barrier (2)
- Brain (2)
- Cerebral amyloid angiopathy (2)
- Cytochrome P450 (2)
- Erythropoietin (2)
- Hemosiderin (2)
- Histidine (2)
- Microdialysis (2)
- Microsomes (2)
- Midazolam hydroxylation (2)
- Monoclonal antibody (2)
- Monoterpenes (2)
- Opioid (2)
- PK/PD (2)
- Publication Year
- Publication
-
- Pharmacy Faculty Articles and Research (47)
- Honors Theses (4)
- Mathematics, Physics, and Computer Science Faculty Articles and Research (4)
- Biology, Chemistry, and Environmental Sciences Faculty Articles and Research (3)
- Pharmacy Faculty Books and Book Chapters (2)
-
- Physician Assistant Capstones, 2016 to 2019 (2)
- Theses and Dissertations (2)
- All Master's Theses (1)
- Articles (1)
- Biological Sciences Theses and Dissertations (1)
- Biomedical Engineering ETDs (1)
- Boise State University Theses and Dissertations (1)
- Capstone Showcase (1)
- Chemistry & Biochemistry Undergraduate Honors Theses (1)
- Clinical Research in Practice: The Journal of Team Hippocrates (1)
- D.U.Quark (1)
- Dissertations and Theses (Open Access) (1)
- Dissertations, Theses, and Capstone Projects (1)
- English Department: Research for Change - Wicked Problems in Our World (1)
- Honors Undergraduate Theses (1)
- Intuition: The BYU Undergraduate Journal of Psychology (1)
- Journal of Food and Drug Analysis (1)
- Library Articles and Research (1)
- Master's Theses (1)
- Nursing Leadership in Community Engagement Projects (1)
- PANDION: The Osprey Journal of Research and Ideas (1)
- Pitzer Senior Theses (1)
- Psychology Faculty Articles and Research (1)
- Research Colloquium (1)
- SC Upstate Research Symposium (1)
- Publication Type
- File Type
Articles 91 - 101 of 101
Full-Text Articles in Pharmaceutical Preparations
Pharmacokinetic/Pharmacodynamic (Pk/Pd) Modeling Of Anti-Neoplastic Agents, Daniel Lexcen, Ahmed H. Salem, Walid F. Elkhatib, Virginia Haynes, Ayman Noreddin
Pharmacokinetic/Pharmacodynamic (Pk/Pd) Modeling Of Anti-Neoplastic Agents, Daniel Lexcen, Ahmed H. Salem, Walid F. Elkhatib, Virginia Haynes, Ayman Noreddin
Pharmacy Faculty Books and Book Chapters
"Development of tumor resistance to chemotherapeutics is related to inherent tumor variations regarding sensitivity to chemotherapeutics and to sub-optimal dosing regimens, including variation in patient pharmacokinetics that result in suboptimal exposure of tumor cells to anti-neoplastic drugs [1, 2]. The rate and extent of drug efficacy depends on the extent of drug exposure at the tumor site and the time above the effective concentration [3]. In vitro models that incorporate these pharmacokinetic and pharmacodynamic (PK/PD) principles to optimize therapeutic response may be considered the method of choice for optimizing dosing schedules before translating data from static assays to animals and …
Application Of Pharmacokinetics/Pharmacodynamics (Pk/Pd) In Designing Effective Antibiotic Treatment Regimens, Ghada F. Ahmed, Ayman Noreddin
Application Of Pharmacokinetics/Pharmacodynamics (Pk/Pd) In Designing Effective Antibiotic Treatment Regimens, Ghada F. Ahmed, Ayman Noreddin
Pharmacy Faculty Books and Book Chapters
"Designing antibiotic dosing regimens is often not optimal and the dose-response relationship for most antibiotics is not well-known1. Both Pharmacokinetics (PK) and Pharmacodynamics (PD) are characteristics of antimicrobial agents that should be considered in the development of effective antibiotic therapy. By linking the concentration time profile at the site of action to the drug effect (PK/PD), the effect of varying dosage regimens against pathogens could be simulated enabling the identification of effective dosage strategies. It is known that inadequate antibiotic dosing could not only lead to a therapeutic failure, but also to the development of bacterial resistance. Importantly, the evolution …
Ginkgo Extract Egb761 Confers Neuroprotection By Reduction Of Glutamate Release In Ischemic Brain, Alexander Mdzinarishvili, Rachita K. Sumbria, Dorothee Lang, Jochen Klein
Ginkgo Extract Egb761 Confers Neuroprotection By Reduction Of Glutamate Release In Ischemic Brain, Alexander Mdzinarishvili, Rachita K. Sumbria, Dorothee Lang, Jochen Klein
Pharmacy Faculty Articles and Research
Purpose - Ginkgo extract EGb761 has shown anti-edema and anti-ischemic effects in various experimental models. In the present study, we demonstrate neuroprotective effects of EGb761 in experimental stroke while monitoring brain metabolism by microdialysis. Methods - We have used oxygen-glucose deprivation in brain slices in vitro and middle cerebral artery occlusion (MCAO) in vivo to induce ischemia in mouse brain. We used microdialysis in mouse striatum to monitor extracellular concentrations of glucose and glutamate. Results - In vitro, EGb761 reduced ischemia-induced cell swelling in hippocampal slices by 60%. In vivo, administration of EGb761 (300 mg/kg) reduced cell degeneration and edema …
Bsa Nanoparticles For Sirna Delivery: Coating Effects On Nanoparticle Properties, Plasma Protein Adsorption, And In Vitro Sirna Delivery, Haran Yogasundaram, Markian Stephan Bahniuk, Harsh-Deep Singh, Hamidreza Montazeri Aliabadi, Hasan Uludag, Larry David Unsworth
Bsa Nanoparticles For Sirna Delivery: Coating Effects On Nanoparticle Properties, Plasma Protein Adsorption, And In Vitro Sirna Delivery, Haran Yogasundaram, Markian Stephan Bahniuk, Harsh-Deep Singh, Hamidreza Montazeri Aliabadi, Hasan Uludag, Larry David Unsworth
Pharmacy Faculty Articles and Research
Developing vehicles for the delivery of therapeutic molecules, like siRNA, is an area of active research. Nanoparticles composed of bovine serum albumin, stabilized via the adsorption of poly-L-lysine (PLL), have been shown to be potentially inert drug-delivery vehicles. With the primary goal of reducing nonspecific protein adsorption, the effect of using comb-type structures of poly(ethylene glycol) (1 kDa, PEG) units conjugated to PLL (4.2 and 24 kDa) on BSA-NP properties, apparent siRNA release rate, cell viability, and cell uptake were evaluated. PEGylated PLL coatings resulted in NPs with ζ-potentials close to neutral. Incubation with platelet-poor plasma showed the composition of …
Neuroprotective Effects Of Bilobalide Are Accompanied By A Reduction Of Ischemia-Induced Glutamate Release In Vivo, Dorothee Lang, Cornelia Kiewert, Alexander Mdzinarishvili, Tina Maria Schwarzkopf, Rachita K. Sumbria, Joachim Hartmann, Jochen Klein
Neuroprotective Effects Of Bilobalide Are Accompanied By A Reduction Of Ischemia-Induced Glutamate Release In Vivo, Dorothee Lang, Cornelia Kiewert, Alexander Mdzinarishvili, Tina Maria Schwarzkopf, Rachita K. Sumbria, Joachim Hartmann, Jochen Klein
Pharmacy Faculty Articles and Research
Neuroprotective properties of bilobalide, a specific constituent of Ginkgo extracts, were tested in a mouse model of stroke. After 24 h of middle cerebral artery occlusion (MCAO), bilobalide reduced infarct areas in the core region (striatum) by 40–50% when given at 10 mg/kg 1 h prior to MCAO. Neuroprotection was also observed at lower doses, or when the drug was given 1 h past stroke induction. Sensorimotor function in mice was improved by bilobalide as shown by corner and chimney tests. When brain metabolism in situ was monitored by microdialysis, MCAO caused a rapid disappearance of extracellular glucose in the …
Unifying The Mathematical Modeling Of In Vivo And In Vitro Microdialysis, Peter M. Bungay, Rachita K. Sumbria, Ulrich Bickel
Unifying The Mathematical Modeling Of In Vivo And In Vitro Microdialysis, Peter M. Bungay, Rachita K. Sumbria, Ulrich Bickel
Pharmacy Faculty Articles and Research
A unifying approach is presented for developing mathematical models of microdialysis that are applicable to both in vitro and in vivo situations. Previous models for cylindrical probes have been limited by accommodating analyte diffusion through the surrounding medium in the radial direction only, i.e., perpendicular to the probe axis, or by incomplete incorporation of diffusion in the axial direction. Both radial and axial diffusion are included in the present work by employing two-dimensional finite element analysis. As in previous models, the nondimensional clearance modulus (Θ) represents the degree to which analyte clearance from the external medium influences diffusion through the …
Incentives For Orphan Drug Research And Development In The United States, Enrique Seoane-Vazquez, Rosa Rodriguez-Monguio, Sheryl L. Szeinbach, Jay Visaria
Incentives For Orphan Drug Research And Development In The United States, Enrique Seoane-Vazquez, Rosa Rodriguez-Monguio, Sheryl L. Szeinbach, Jay Visaria
Pharmacy Faculty Articles and Research
Background: The Orphan Drug Act (1983) established several incentives to encourage the development of orphan drugs (ODs) to treat rare diseases and conditions. This study analyzed the characteristics of OD designations, approvals, sponsors, and evaluated the effective patent and market exclusivity life of orphan new molecular entities (NMEs) approved in the US between 1983 and 2007.
Methods: Primary data sources were the FDA Orange Book, the FDA Office of Orphan Drugs Development, and the US Patent and Trademark Office. Data included all orphan designations and approvals listed by the FDA and all NMEs approved by the FDA during …
Common And Distinct Mechanisms Of Different Redox-Active Carcinogens Involved In The Transformation Of Mouse Jb6p+ Cells, Sun Yang, Bobbye J. Misner, Rita Chiu, Frank L. Meyskens Jr.
Common And Distinct Mechanisms Of Different Redox-Active Carcinogens Involved In The Transformation Of Mouse Jb6p+ Cells, Sun Yang, Bobbye J. Misner, Rita Chiu, Frank L. Meyskens Jr.
Pharmacy Faculty Articles and Research
We transformed JB6P+ cells with prolonged intermittent low-dose UVB radiation or prolonged exposure to low-dose H2O2 or CdCl2. Stable transformation was confirmed by an anchorage-independence assay. The JB6P+ transformants formed more colonies (∼six folds) in soft agar as compared to their JB6P+ parent cells and were associated with increased intracellular reactive oxygen species (ROS) levels. Activating protein-1 (AP-1) is a family of transcription factors that are rapidly activated by elevated intracellular ROS levels, and their composition is important in the process of cellular transformation and/or tumor progression. To investigate if carcinogenesis induced by distinct carcinogens was via similar molecular mechanisms …
Cost Prevention Of Hiv, Jerika Lam
Cost Prevention Of Hiv, Jerika Lam
Pharmacy Faculty Articles and Research
"Since the introduction of highly active antiretroviral therapy (HAART) in the late 1990s, management of patients with human immunodeficiency virus (HIV) infection has improved where they are living longer and with fewer incidences of opportunistic illnesses. Furthermore, significant progress has been made in the understanding of the disease, the ability to quantify viral load and correlate with clinical outcomes, genotypic and phenotypic resistance assays designed to assess viral susceptibility, and a heightened awareness and appreciation of the importance of treatment adherence to ensure virologic suppression.' In spite of the benefits that HIV-infected patients may have acquired in terms of more …
Antioxidation Activity Of Dhea And Its Mechanisms, Sun Yang, Han Rui
Antioxidation Activity Of Dhea And Its Mechanisms, Sun Yang, Han Rui
Pharmacy Faculty Articles and Research
Objective: The aim of this study was to determine the anti-oxidative activity of a new chemopreventive agent--dehydroepiandrosterone (DHEA), and the mechanisms of action by which DHEA protect the thymocytes and DNA from oxidative damage. Methods: Agarose gel electrophoresis, flow cytometry, single cel! gel electrophoresis, chemiluminescence assay, triazolyl blue tetrazolumbromide (MTT) colorimetry, and three dimensional collagen gel assay were used. Results: In agarose gel electrophoresis, 10 nmol/L DHEA blocked the typical DNA degradation (DNA Ladder) induced by H2O2. DHEA 2. 5 nmol/L and 10 nmol/L both significantly decreased the percentage of characteristic apoptotic DNA …
Fatty Liver And Metabolism Of Xenobiotics In The Rat, Joyce D. Stone
Fatty Liver And Metabolism Of Xenobiotics In The Rat, Joyce D. Stone
Theses and Dissertations (ETD)
No abstract provided.